Squamous Cell Carcinoma: Restaging and Response to Therapy.
Publication
, Journal Article
Subramaniam, RM; Lowe, VJ
Published in: PET Clin
October 2007
This article describes the use of 18F-fluorodeoxyglucose PET in patients who have head and neck cancer for assessment of therapy response, detection of locoregional recurrence and distant metastasis, and surveillance.
Duke Scholars
Published In
PET Clin
DOI
ISSN
1556-8598
Publication Date
October 2007
Volume
2
Issue
4
Start / End Page
481 / 487
Location
United States
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Subramaniam, R. M., & Lowe, V. J. (2007). Squamous Cell Carcinoma: Restaging and Response to Therapy. PET Clin, 2(4), 481–487. https://doi.org/10.1016/j.cpet.2008.05.008
Subramaniam, Rathan M., and Val J. Lowe. “Squamous Cell Carcinoma: Restaging and Response to Therapy.” PET Clin 2, no. 4 (October 2007): 481–87. https://doi.org/10.1016/j.cpet.2008.05.008.
Subramaniam RM, Lowe VJ. Squamous Cell Carcinoma: Restaging and Response to Therapy. PET Clin. 2007 Oct;2(4):481–7.
Subramaniam, Rathan M., and Val J. Lowe. “Squamous Cell Carcinoma: Restaging and Response to Therapy.” PET Clin, vol. 2, no. 4, Oct. 2007, pp. 481–87. Pubmed, doi:10.1016/j.cpet.2008.05.008.
Subramaniam RM, Lowe VJ. Squamous Cell Carcinoma: Restaging and Response to Therapy. PET Clin. 2007 Oct;2(4):481–487.
Published In
PET Clin
DOI
ISSN
1556-8598
Publication Date
October 2007
Volume
2
Issue
4
Start / End Page
481 / 487
Location
United States
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3211 Oncology and carcinogenesis